A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

Clinical trial NCT06205524 · UNKNOWN

Trial details

NCT number: NCT06205524
Sponsor: National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 COVID-19 Immunisation

Start date: 2023-07-10
Primary completion: 2024-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.